Business Name: |
Centagen |
Contact Person: |
Bryant Villeponteau, Owner |
Address: |
4953 Smith Canyon Court, San Diego, California 92130 |
Phone Number: |
(858) 380-5131 |
Website Address: |
centagen.com |
Annual Revenue (USD): |
$2.500.000 to $4.999.999 |
Founding Year: |
2007 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2B & B2C |
Business Category: |
|
SIC Code: |
2834 |
NAICS Code: |
3254120 |
Share This Business: |
|
Related Businesses: |
Sunovion Pharmaceuticals Inc - San Diego, CA 92130 Ocera Therapeutics Inc - San Diego, CA 92130 Zogenix Inc - San Diego, CA 92130 Soledad Pharmaceuticals - San Diego, CA 92130 Surefire Diagnostics - San Diego, CA 92130 Mei Pharma Inc - San Diego, CA 92130 Sunovion Respiratory Development Inc - San Diego, CA 92130 Stratum Medical Corp - San Diego, CA 92130 Kuki Atsuo - San Diego, CA 92130 Elcelyx Therapeutics Inc - San Diego, CA 92130 Calixa Therapeutics Inc - San Diego, CA 92130 Ingenome Inc - San Diego, CA 92130 Ader Enterprises Inc - San Diego, CA 92130 Remora Pharmaceuticals Inc - San Diego, CA 92130 Adamis Pharmaceuticals Corp - San Diego, CA 92130 Brighton Pharmaceuticals Inc - San Diego, CA 92130 Sequel Pharmaceuticals Inc - San Diego, CA 92130 Oprx Pharmaceuticals Inc - San Diego, CA 92130 Sequel Pharmaceuticals - San Diego, CA 92130 Nerveda Inc - San Diego, CA 92130 |
The company Centagen provides BOTH services in the form of from its single location in California.
1 to 4 employees work for Centagen, and the business now earns $2.500.000 to $4.999.999 per annum.
Centagen was launched in 2007 and is classified under SIC code and category 2834 , and NAICS number and grouping 3254120 .
To contact Centagen, please call Bryant Villeponteau, Owner with the phone number (858) 380-5131 or visit its single location at 4953 Smith Canyon Court in San Diego, California 92130.
The location of the single location can also be found using the coordinates 32.952591,-117.210796.
Read more details about this business on the webpage centagen.com or follow the company’s social media accounts, on Twitter and on Facebook.